Investing in mid-cap stocks is essential for investors who prefer a diversified portfolio. These stocks offer a middle ground with regard to the risks and rewards when compared to the small-cap and large-cap companies.
In terms of stability, these stocks are less volatile than the small-cap stocks, and in terms of performance, the mid-cap stocks are usually better than their large-cap counterparts. Let’s take a look at the five best and worst performing mid-cap stocks in August 2022.
5 Best-Performing Mid-Cap Stocks In August 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.
5. Axsome Therapeutics (72%)
Founded in 2012 and headquartered in New York City, Axsome Therapeutics (NASDAQ:AXSM) company develops novel therapies for managing central nervous system disorders. The shares are up by almost 57% year to date and up almost 161% in the last three months.
As of this writing, Axsome Therapeutics shares are trading at above $58 (52-week range of $20.63 to $71.98), giving it a market capitalization of more than $2.30 billion.
4. AST Spacemobile (80%)
Founded in 2017 and headquartered in Midland, Texas, Ast Spacemobile (NASDAQ:ASTS) is building a broadband cellular network in space for unmodified mobile devices. The shares are up by over 7% year to date and up over 33% in the last three months.
As of this writing, AST SpaceMobile shares are trading at above $8.30 (52-week range of $4.84 to $14.27), giving it a market capitalization of more than $1.50 billion.
3. Karuna Theapeutics (106%)
Founded in 2009 and headquartered in Boston, Karuna Therapeutics (NASDAQ:KRTX) develops therapies using muscarinic cholinergic receptors for the treatment of psychosis and cognitive impairment.The shares are up by almost 83% year to date and up over 128% in the last three months.
As of this writing, Karuna Therapeutics shares are trading at above $239 (52-week range of $92.26 to $278.25), giving it a market capitalization of more than $7.90 billion.
2 Global Blood Therapeutics (106%)
Founded in 2011 and headquartered in South San Francisco, Calif., Global Blood Therapeutics (NASDAQ:GBT) discovers, develops and commercializes novel therapeutics for the treatment of grievous blood-based disorders. The shares are up by over 131% year to date and up over 150% in the last three months.
As of this writing, Global Blood Therapeutics shares are trading at above $67 (52-week range of $21.65 to $73.02), giving it a market capitalization of more than $4.50 billion.
1. ChemoCentryx (119%)
Founded in 1997 and headquartered in San Carlos, Calif., ChemoCentryx (NASDAQ:CCXI) is a biopharmaceutical company that develops and commercializes medicines for inflammatory disorders, autoimmune diseases, and cancer. The shares are up by over 41% year to date and up over 100% in the last three months.
As of this writing, ChemoCentryx shares are trading at above $51 (52-week range of $14.95 to $51.78), giving it a market capitalization of more than $3.60 billion.
5 Worst-Performing Mid-Cap Stocks In August 2022
5. MultiPlan (-32%)
Founded in 1980 and headquartered in New York City, MultiPlan (NYSE:MPLN) offers healthcare cost management solutions. The shares are down by over 33% year to date and down almost 46% in the last three months.
As of this writing, MultiPlan shares are trading at above $2.90 (52-week range of $2.8800 to $6.2600), giving it a market capitalization of almost $2 billion.
4. Tandem Diabetes Care (-33%)
Founded in 2006 and headquartered in San Diego, Tandem Diabetes Care (NASDAQ:TNDM) designs, develops and commercializes products for people with insulin-dependent diabetes. The shares are down by over 63% year to date and down almost 3% in the last three months.
As of this writing, Tandem Diabetes Care shares are trading at above $55 (52-week range of $42.90 to $155.86), giving it a market capitalization of more than $3.60 billion.
3. Getty Images Holdings (-40%)
Founded in 1995 and headquartered in Seattle, Getty Images (NYSE:GETY) is a visual media company that offers stock images, editorial photography, video and music to businesses and everyday users. The shares are down by over 15% year to date and down over 16% in the last three months.
As of this writing, Getty Images shares are trading at above $8.10 (52-week range of $7.86 to $37.88), giving it a market capitalization of more than $3.60 billion.
2. Novavaz (-43%)
Founded in 1987 and headquartered in Gaithersburg, Md., Novavax (NASDAQ:NVAX) discovers, develops and commercializes medicines to prevent infectious diseases. The shares are down by over 79% year to date and down over 26% in the last three months.
As of this writing, Novavax shares are trading at above $29 (52-week range of $28.25 to $260.69), giving it a market capitalization of more than $2.30 billion.
1. SiTime (-46%)
Founded in 2005 and headquartered in Santa Clara, Calif., Sitime Corporation (NASDAQ:SITM) is a micro-electromechanical system based silicon timing solution company. The shares are down by over 70% year to date and down almost 47% in the last three months.
As of this writing, SiTime shares are trading at above $88 (52-week range of $85.00 to $341.77), giving it a market capitalization of almost $2 billion.